08/06/2026
Cell therapies have the potential to transform treatment for many diseases, but manufacturing them remains a major challenge.
Logicyte, winner of the inaugural Biolocity Pitch Competition Award, is working to change that. The startup is developing technology that can monitor cell therapy production, predict errors, and automate key manufacturing steps to improve efficiency and reliability.
The competition brought together innovators, investors, entrepreneurs, and commercialization experts to help move promising biomedical technologies closer to patient impact.
Learn more about Logicyte and its award-winning technology:
🔗 https://bit.ly/logicyte